Aβ seeds resist inactivation by formaldehyde - Acta Neuropathologica
- ️Jucker, Mathias
- ️Sat Sep 06 2014
Abstract
Cerebral β-amyloidosis can be exogenously induced by the intracerebral injection of brain extracts containing aggregated β-amyloid (Aβ) into young, pre-depositing Aβ precursor protein- (APP) transgenic mice. Previous work has shown that the induction involves a prion-like seeding mechanism in which the seeding agent is aggregated Aβ itself. Here we report that the β-amyloid-inducing activity of Alzheimer’s disease (AD) brain tissue or aged APP-transgenic mouse brain tissue is preserved, albeit with reduced efficacy, after formaldehyde fixation. Moreover, spectral analysis with amyloid conformation-sensitive luminescent conjugated oligothiophene dyes reveals that the strain-like properties of aggregated Aβ are maintained in fixed tissues. The resistance of Aβ seeds to inactivation and structural modification by formaldehyde underscores their remarkable durability, which in turn may contribute to their persistence and spread within the body. The present findings can be exploited to establish the relationship between the molecular structure of Aβ aggregates and the variable clinical features and disease progression of AD even in archived, formalin-fixed autopsy material.
Access this article
Subscribe and save
- Get 10 units per month
- Download Article/Chapter or eBook
- 1 Unit = 1 Article or 1 Chapter
- Cancel anytime
Buy Now
Price excludes VAT (USA)
Tax calculation will be finalised during checkout.
Instant access to the full article PDF.
Similar content being viewed by others
References
Bondolfi L, Calhoun M, Ermini F, Kuhn HG, Wiederhold K-H, Walker L, Staufenbiel M, Jucker M (2002) Amyloid-associated neuron loss and gliogenesis in the neocortex of amyloid precursor protein transgenic mice. J Neurosci 22:515–522
Brown F (2001) Inactivation of viruses by aziridines. Vaccine 20:322–327
Brown P, Brandel J-P, Sato T, Nakamura Y, MacKenzie J, Will RG, Ladogana A, Pocchiari M, Leschek EW, Schonberger LB (2012) Iatrogenic Creutzfeldt-Jakob disease, final assessment. Emerging Infect Dis 18:901–907. doi:10.3201/eid1806.120116
Brown P, Gibbs CJ, Gajdusek DC, Cathala F, LaBauge R (1986) Transmission of Creutzfeldt-Jakob disease from formalin-fixed, paraffin-embedded human brain tissue. N Engl J Med 315:1614–1615. doi:10.1056/NEJM198612183152516
Brown P, Liberski PP, Wolff A, Gajdusek DC (1990) Resistance of scrapie infectivity to steam autoclaving after formaldehyde fixation and limited survival after ashing at 360 degrees C: practical and theoretical implications. J Infect Dis 161:467–472
Brown P, Wolff A, Gajdusek DC (1990) A simple and effective method for inactivating virus infectivity in formalin-fixed tissue samples from patients with Creutzfeldt-Jakob disease. Neurology 40:887–890
Delrue I, Verzele D, Madder A, Nauwynck HJ (2012) Inactivated virus vaccines from chemistry to prophylaxis: merits, risks and challenges. Expert Rev Vaccines 11:695–719. doi:10.1586/erv.12.38
Eisele YS, Bolmont T, Heikenwalder M, Langer F, Jacobson LH, Yan Z-X, Roth K, Aguzzi A, Staufenbiel M, Walker LC, Jucker M (2009) Induction of cerebral beta-amyloidosis: intracerebral versus systemic Abeta inoculation. Proc Natl Acad Sci 106:12926–12931. doi:10.1073/pnas.0903200106
Eisele YS, Obermüller U, Heilbronner G, Baumann F, Kaeser SA, Wolburg H, Walker LC, Staufenbiel M, Heikenwalder M, Jucker M (2010) Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis. Science 330:980–982. doi:10.1126/science.1194516
Gordon WS (1946) Advances in veterinary research. Vet Rec 58:516–525
Hamaguchi T, Eisele YS, Varvel NH, Lamb BT, Walker LC, Jucker M (2012) The presence of Aβ seeds, and not age per se, is critical to the initiation of Aβ deposition in the brain. Acta Neuropathol 123:31–37. doi:10.1007/s00401-011-0912-1
Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297:353–356. doi:10.1126/science.1072994
Heilbronner G, Eisele YS, Langer F, Kaeser SA, Novotny R, Nagarathinam A, Aslund A, Hammarström P, Nilsson KPR, Jucker M (2013) Seeded strain-like transmission of β-amyloid morphotypes in APP transgenic mice. EMBO Rep 14:1017–1022. doi:10.1038/embor.2013.137
Holtzman DM, Mandelkow E, Selkoe DJ (2012) Alzheimer disease in 2020. Cold Spring Harb Perspect Med. doi:10.1101/cshperspect.a011585
Irwin DJ, Abrams JY, Schonberger LB, Leschek EW, Mills JL, Lee VM-Y, Trojanowski JQ (2013) Evaluation of potential infectivity of Alzheimer and Parkinson disease proteins in recipients of cadaver-derived human growth hormone. JAMA Neurol 70:462. doi:10.1001/jamaneurol.2013.1933
Jucker M, Walker LC (2013) Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature 501:45–51. doi:10.1038/nature12481
Kane MD, Lipinski WJ, Callahan MJ, Bian F, Durham RA, Schwarz RD, Roher AE, Walker LC (2000) Evidence for seeding of beta-amyloid by intracerebral infusion of Alzheimer brain extracts in beta-amyloid precursor protein-transgenic mice. J Neurosci 20:3606–3611
Klingstedt T, Aslund A, Simon RA, Johansson LBG, Mason JJ, Nyström S, Hammarström P, Nilsson KPR (2011) Synthesis of a library of oligothiophenes and their utilization as fluorescent ligands for spectral assignment of protein aggregates. Org Biomol Chem 9:8356–8370. doi:10.1039/c1ob05637a
Langer F, Eisele YS, Fritschi SK, Staufenbiel M, Walker LC, Jucker M (2011) Soluble A{beta} seeds Are potent inducers of cerebral {beta}-amyloid deposition. J Neurosci 31:14488–14495. doi:10.1523/JNEUROSCI.3088-11.2011
Meyer-Luehmann M, Coomaraswamy J, Bolmont T, Kaeser S, Schaefer C, Kilger E, Neuenschwander A, Abramowski D, Frey P, Jaton AL, Vigouret J-M, Paganetti P, Walsh DM, Mathews PM, Ghiso J, Staufenbiel M, Walker LC, Jucker M (2006) Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science 313:1781–1784. doi:10.1126/science.1131864
Morales R, Duran-Aniotz C, Castilla J, Estrada LD, Soto C (2011) De novo induction of amyloid-β deposition in vivo. Mol Psychiatry 17:1347–1353. doi:10.1038/mp.2011.120
Nagarathinam A, Höflinger P, Bühler A, Schäfer C, McGovern G, Jeffrey M, Staufenbiel M, Jucker M, Baumann F (2013) Membrane-anchored aβ accelerates amyloid formation and exacerbates amyloid-associated toxicity in mice. J Neurosci 33:19284–19294. doi:10.1523/JNEUROSCI.2542-13.2013
Pattison IH (1965) Resistance of the scrapie agent to formalin. J Comp Pathol 75:159–164
Pattison IH (1972) Scrapie—a personal view. J Clin Pathol Suppl (R Coll Pathol) 6:110–114
Prusiner SB (1998) Prions. Proc Natl Acad Sci USA 95:13363–13383
Prusiner SB (2013) Biology and genetics of prions causing neurodegeneration. Annu Rev Genet 47:601–623. doi:10.1146/annurev-genet-110711-155524
Radde R, Bolmont T, Kaeser SA, Coomaraswamy J, Lindau D, Stoltze L, Calhoun ME, Jäggi F, Wolburg H, Gengler S, Haass C, Ghetti B, Czech C, Hölscher C, Mathews PM, Jucker M (2006) Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology. EMBO Rep 7:940–946. doi:10.1038/sj.embor.7400784
Rosen RF, Fritz JJ, Dooyema J, Cintron AF, Hamaguchi T, Lah JJ, Levine H, Jucker M, Walker LC (2012) Exogenous seeding of cerebral β-amyloid deposition in βAPP-transgenic rats. J Neurochem 120:660–666. doi:10.1111/j.1471-4159.2011.07551.x
Rutala WA, Weber DJ, Society for Healthcare Epidemiology of America (2010) Guideline for disinfection and sterilization of prion-contaminated medical instruments. Infect Control Hosp Epidemiol 31:107–117. doi:10.1086/650197
Stöhr J, Watts JC, Mensinger ZL, Oehler A, Grillo SK, DeArmond SJ, Prusiner SB, Giles K (2012) Purified and synthetic Alzheimer’s amyloid beta (Aβ) prions. Proc Natl Acad Sci 109:11025–11030. doi:10.1073/pnas.1206555109
Sturchler-Pierrat C, Abramowski D, Duke M, Wiederhold KH, Mistl C, Rothacher S, Ledermann B, Bürki K, Frey P, Paganetti PA, Waridel C, Calhoun ME, Jucker M, Probst A, Staufenbiel M, Sommer B (1997) Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci USA 94:13287–13292
Taylor DM, Brown JM, Fernie K, McConnell I (1997) The effect of formic acid on BSE and scrapie infectivity in fixed and unfixed brain-tissue. Vet Microbiol 58:167–174
Taylor DM, McConnell I (1988) Autoclaving does not decontaminate formol-fixed scrapie tissues. Lancet 1:1463–1464
Walker LC, Callahan MJ, Bian F, Durham RA, Roher AE, Lipinski WJ (2002) Exogenous induction of cerebral beta-amyloidosis in betaAPP-transgenic mice. Peptides 23:1241–1247
Watts JC, Giles K, Grillo SK, Lemus A, DeArmond SJ, Prusiner SB (2011) Bioluminescence imaging of Abeta deposition in bigenic mouse models of Alzheimer’s disease. Proc Natl Acad Sci 108:2528–2533. doi:10.1073/pnas.1019034108
Acknowledgments
We would like to thank Matthias Staufenbiel for the APP23 tg mice and comments on the manuscript; Markus Fändrich (Ulm, Germany) for the recombinant Aβ; Yvonne Eisele, Jan Winchenbach, Maria Mina, Christian Krüger, Ulrike Obermüller, Jörg Odenthal, Jeromy Dooyema, Sofie Nyström and many other members of our departments for experimental help and discussions. The assistance of Jay Rasmussen (Lethbridge, Canada) and Rodrigo Morales (Houston, USA) is greatly appreciated. This work was supported by grants from the Competence Network on Degenerative Dementias (BMBF-01GI0705), the National Institutes of Health (R21AG040589, P51RR165, P51OD11132 and R36AG043646), the MetLife Foundation, and by the Swedish Research Council.
Author information
Authors and Affiliations
German Center for Neurodegenerative Diseases (DZNE), 72076, Tübingen, Germany
Sarah K. Fritschi, Lan Ye, Jasmin Mahler, Anika Bühler, Frank Baumann, Manuela Neumann & Mathias Jucker
Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, 72076, Tübingen, Germany
Sarah K. Fritschi, Lan Ye, Jasmin Mahler, Anika Bühler, Frank Baumann & Mathias Jucker
Graduate School of Cellular and Molecular Neuroscience, University of Tübingen, 72074, Tübingen, Germany
Sarah K. Fritschi, Lan Ye & Jasmin Mahler
Yerkes National Primate Research Center, Emory University, Atlanta, GA, 30329, USA
Amarallys Cintron & Lary C. Walker
Department of Neurology, Emory University, Atlanta, GA, 30322, USA
Lary C. Walker
Department of Neuropathology, University of Tübingen, 72076, Tübingen, Germany
Manuela Neumann
Department of Chemistry, IFM, Linköping University, 581 83, Linköping, Sweden
K. Peter R. Nilsson & Per Hammarström
Authors
- Sarah K. Fritschi
You can also search for this author inPubMed Google Scholar
- Amarallys Cintron
You can also search for this author inPubMed Google Scholar
- Lan Ye
You can also search for this author inPubMed Google Scholar
- Jasmin Mahler
You can also search for this author inPubMed Google Scholar
- Anika Bühler
You can also search for this author inPubMed Google Scholar
- Frank Baumann
You can also search for this author inPubMed Google Scholar
- Manuela Neumann
You can also search for this author inPubMed Google Scholar
- K. Peter R. Nilsson
You can also search for this author inPubMed Google Scholar
- Per Hammarström
You can also search for this author inPubMed Google Scholar
- Lary C. Walker
You can also search for this author inPubMed Google Scholar
- Mathias Jucker
You can also search for this author inPubMed Google Scholar
Corresponding authors
Correspondence to Lary C. Walker or Mathias Jucker.
Additional information
S. K. Fritschi and A. Cintron contributed equally.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Fritschi, S.K., Cintron, A., Ye, L. et al. Aβ seeds resist inactivation by formaldehyde. Acta Neuropathol 128, 477–484 (2014). https://doi.org/10.1007/s00401-014-1339-2
Received: 21 July 2014
Revised: 29 August 2014
Accepted: 29 August 2014
Published: 06 September 2014
Issue Date: October 2014
DOI: https://doi.org/10.1007/s00401-014-1339-2